Growth factor delivery for tissue engineering

被引:328
作者
Babensee, JE [1 ]
McIntire, LV [1 ]
Mikos, AG [1 ]
机构
[1] Rice Univ, Inst Biosci & Bioengn, Dept Bioengn, Houston, TX 77005 USA
关键词
tissue engineering; growth factors; controlled release; bone; nerve; liver;
D O I
10.1023/A:1007502828372
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A tissue-engineered implant is a biologic-biomaterial combination in which some component of tissue has been combined with a biomaterial to create a device for the restoration or modification of tissue or organ function. Specific growth factors, released from a delivery device or from co-transplanted cells. would aid in the induction of host paraenchymal cell infiltration and improve engraftment of co-delivered cells for more efficient tissue regeneration or ameliorate disease states. The characteristic properties of growth factors are described to provide a biological basis for their use in tissue engineered devices. The principles of polymeric device development for therapeutic growth factor delivery in the context of tissue engineering are outlined. A review of experimental evidence illustrates examples of growth factor delivery from devices such as micropaticles. scaffolds, and encapsulated cells, for their use in the application areas of musculoskeletal tissue, neural tissue, and hepatic tissue.
引用
收藏
页码:497 / 504
页数:8
相关论文
共 109 条
[1]   Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients [J].
Aebischer, P ;
Schluep, M ;
Deglon, N ;
Joseph, JM ;
Hirt, L ;
Heyd, B ;
Goddard, M ;
Hammang, JP ;
Zurn, AD ;
Kato, AC ;
Regli, F ;
Baetge, EE .
NATURE MEDICINE, 1996, 2 (06) :696-699
[2]   BASIC FIBROBLAST GROWTH-FACTOR RELEASED FROM SYNTHETIC GUIDANCE CHANNELS FACILITATES PERIPHERAL-NERVE REGENERATION ACROSS LONG NERVE GAPS [J].
AEBISCHER, P ;
SALESSIOTIS, AN ;
WINN, SR .
JOURNAL OF NEUROSCIENCE RESEARCH, 1989, 23 (03) :282-289
[3]   Angiogenic growth factors: A review for tissue engineering [J].
Ahrendt, G ;
Chickering, DE ;
Ranieri, JP .
TISSUE ENGINEERING, 1998, 4 (02) :117-130
[4]  
Anderson JM, 1998, FRONTIERS TISSUE ENG, P152
[5]   Effect of controlled release of platelet-derived growth factor from a porous hydroxyapatite implant on bone ingrowth [J].
Arm, DM ;
Tencer, AF ;
Bain, SD ;
Celino, D .
BIOMATERIALS, 1996, 17 (07) :703-709
[6]   Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells [J].
Asahina, I ;
Sampath, TK ;
Hauschka, PV .
EXPERIMENTAL CELL RESEARCH, 1996, 222 (01) :38-47
[7]   Host response to tissue engineered devices [J].
Babensee, JE ;
Anderson, JM ;
McIntire, LV ;
Mikos, AG .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 33 (1-2) :111-139
[8]  
BAE YH, 1998, FRONTIERS TISSUE ENG, P261
[9]   Materials for protein delivery in tissue engineering [J].
Baldwin, SP ;
Saltzman, WM .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 33 (1-2) :71-86
[10]   Synthesis and biological activity of polyethylene glycol-mouse nerve growth factor conjugate [J].
Belcheva, N ;
Woodrow-Mumford, K ;
Mahoney, MJ ;
Saltzman, WM .
BIOCONJUGATE CHEMISTRY, 1999, 10 (06) :932-937